Please ensure Javascript is enabled for purposes of website accessibility
ORIGINAL PAPER
Speech disfluencies in Parkinson’s disease
 
More details
Hide details
 
Submission date: 2015-10-01
 
 
Final revision date: 2015-12-04
 
 
Acceptance date: 2015-12-04
 
 
Publication date: 2016-01-11
 
 
Medical Studies 2015;31(4):267-270
 
KEYWORDS
TOPICS
ABSTRACT
Introduction: Even though speech disfluency is listed in the clinical description of Parkinson’s disease (PD), its nature, intensity, symptomatology, and the effect on verbal communication have not hitherto been defined.
Aim of the research: The research paper presents the results of studies aimed at the description of speech disfluencies in PD and the influence on verbal communication.
Material and methods: The tests involved 10 patients from 54 to 72 years of age with documented PD, responsive to L-dopa preparations. The principal method of the study was based on the linguistic analysis of the utterances produced by the people with PD.
Results: The intensity of the speech disfluency observed in the utterances of persons with PD ranged from 6.6% to 23.0%, so it was significantly higher than that which is assumed as acceptable (3–5%); the speaking rate of the examined persons ranged from 0.7 syllabes (syl.)/s to 4.0 syl./s, and only 2 examined persons spoke with a rate considered to be correct (4–6 syl./s). This demonstrates that speech disfluency is a communication barrier in PD.
Conclusions: The absence of differentiation in the speech disfluency (SD) severity between different types of verbal utterances (difference not statistically significant) and a specified hierarchy of SD symptoms indicate that the speech disfluency in PD has an essentially organic background and is generated by cognitive, linguistic, and motor deficits resulting from the damage to the central nervous system. This is also confirmed by the established hierarchy of utterances with respect to the SD intensity, not excluding the simultaneous participation of the emotional factor.
REFERENCES (26)
1.
Rzepa T. Psychology of communication for managers [Polish]. AMP Studio Paweł Majewski, Szczecin 2003.
 
2.
Nęcki Z. Interhuman communication [Polish]. Profesjonalna Szkoła Biznesu, Krakow 1996.
 
3.
Bridges instead of walls. On communication between people [Polish]. Stewart J (ed.) PWN, Warsaw 2000.
 
4.
Fiske J. Introduction to studies on communicating [Polish]. ASTRUM, Wrocław 1999.
 
5.
Podemski R, Słotwiński K. Aphasia in neurologist’s practice [Polish]. Neurol Neurochir Pol 2005; 39: 483-5.
 
6.
Walsh K. Clinical neuropsychology [Polish]. Wydawnictwo Naukowe PWN, Warsaw 1998.
 
7.
Tarkowski Z. Stuttering [Polish]. Wydawnictwo Naukowe PWN, Warsaw 2002. Góral-Półrola J. Organic speech non-fluency [Polish]. Fundacja Orator, Lublin 2013.
 
8.
Henry JD, Crawford JR. Verbal fluency deficits in Parkinson’s disease: meta-analysis. J Intern Neuropsychol Soc 2004; 10: 608-22.
 
9.
Goberman A, Blomgren M. Parkinson speech disfluencies: effects of L-dopa related fluctuations. J Fluency Disord 2003; 28: 55-70.
 
10.
Budrewicz S, Słotwiński K, Podemski R. Speech disorders in diseases of the extrapyramidal system [Polish]. Neurol Neurochir Pol 2003; 37: 47-54.
 
11.
Bryll G, Kosztołowicz M. A certain way to establish the assessment of students’ general knowledge [Polish]. Zeszyty Naukowe Wyższej Szkoły Inżynierskiej w Opolu. Series: Matematyka 1980; 33: 33-45.
 
12.
Kurkowski Z. Syllabic test for the evaluation of speech disfluency [Polish]. Instytut Fizjologii i Patologii Słuchu, Warsaw 2003.
 
13.
Tarkowski Z. Stuttering as a disorder of interpersonal communication [Polish]. In: Disorders in the communicative process. Voice, speech, hearing, otolaryngology. Obrębowski A, Tarkowski Z (ed.). Fundacja Orator, Lublin 2003; 151-71.
 
14.
Daly JA, Stafford L. Correlates and consequences of social-communicative anxiety. In: Avoiding communication: shyness, reticence and communication apprehension. Daly JA, McCroskey JC (eds.). Sage Publications, London 1984; 125-43.
 
15.
McCroskey JC, Richmond VP. Willingness to communication. Sage Publications, London 1987; 129-55.
 
16.
Cummings JL. Intelectual impairment in Parkinson disease: clinical, pathologic and biochemical correlates. J Geriatr Psych Neurol 1988; 2: 24-36.
 
17.
Forno LS. Neuropatology of Parkinson disease. J Neuropathol Exp Neurol 1996; 55: 259-72.
 
18.
Osiejuk-Łojek E. Neuropsychological deficits in Parkinson’s disease. In: Relation: brain – behaviour in clinical neuropsychology perspective. Herzyk A, Kądzielawa D. Wydawnictwo UMCS, Lublin 1998; 191-215.
 
19.
Sławek J, Wieczorek D. Cognitive disorders in Parkinson’s disease. The prevalence, pathogenesis and clinical picture: cognitive and mental disorders in Parkinson’s disease and other Parkinsonian syndromes. Sobów T, Sławek J. Wydawnictwo Continuo, Wrocław 2006; 33-74.
 
20.
Taylor AE, Saint-Cyr JA, Lang AE. Frontal lobe dysfunction in Parkinson’s disease. The Cortical Focus of Neostratal outflow. Brain 1986; 109: 845-83.
 
21.
Hugdahl K, Asbjornsen A, Wester K. Memory performance in Parkinson disease. Neuropsychiatry, Neuropsychology and Behavioral Neurology 1993; 6: 170-6.
 
22.
Rowland Lewis P. Neurologia Merritta. Urban & Partner 2004; 680-1.
 
23.
Pawlukowska W, Gołąb-Janowska M, Safranow K, et al. Articulation disorders and duration, severity and L-dopa dosage in idiopathic Parkinson’s disease. Neurol Neurochir Pol 2015; 49: 302-6.
 
24.
Frisina PG, Borod JC, Foldi NS, Tenenbaum H. Depression in Parkinson’s disease: health risks, etiology, and treatment options. Neuropsychiatr Dis Treat 2008; 4: 81-91.
 
25.
Webster R L. Evolution of a target-based behavioral therapy for stutters. J Fluency Disord 1980; 5: 303-20.
 
26.
Martínez-Sánchez F, Meilán JJ, Carro J, et al. Speech rate in Parkinson’s disease: a controlled study. Neurologia 2015 Feb 3.: S0213-4853.
 
eISSN:2300-6722
ISSN:1899-1874
Journals System - logo
Scroll to top